PITT1109: Cardiac Outcome Measures in Children With Muscular Dystrophy

Cooperative International Neuromuscular Research Group5 sites in 1 country48 target enrollmentJanuary 2010

ConditionsDuchenne Muscular Dystrophy Becker Muscular Dystrophy Limb Girdle Muscular Dystrophy

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Duchenne Muscular Dystrophy
Sponsor: Cooperative International Neuromuscular Research Group
Enrollment: 48
Locations: 5
Status: Completed
Last Updated: 13 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

The purpose of the research study is to evaluate different cardiac measures that are obtained by echocardiographic tests in patients with muscular dystrophy.

Detailed Description

The research study will include 50 participants aged 8 to 18 years old (before 18th birthday) with Duchenne, Becker, or autosomal recessive limb-girdle (specifically: LGMD 2C-2F and 2I) muscular dystrophies. Participants will be seen in one of five Cooperative International Neuromuscular Research Group (CINRG) centers located in the United States. All study assessments will be completed in the same day and include reviewing past medical and surgical history, collecting vital signs, collecting cardiac measures through echocardiographic tests.

Registry

clinicaltrials.gov

Start Date

January 2010

End Date

May 2012

Last Updated

13 years ago

Study Type

Observational

Sex

All

Investigators

Sponsor

Cooperative International Neuromuscular Research Group

Responsible Party

Sponsor

Eligibility Criteria

Inclusion Criteria

•Participants must be between the ages of 8 and 18 years old
•Confirmed diagnosis of muscular dystrophy (DMD, BMD, or LGMD 2C-2F and 2I)

Exclusion Criteria

•Investigator assessment of inability to comply with protocol
•History of a congenital cardiac defect or other cardiac disease unrelated to muscular dystrophy